Publication Cover
Redox Report
Communications in Free Radical Research
Volume 6, 2001 - Issue 3
738
Views
25
CrossRef citations to date
0
Altmetric
Miscellany

The role of cerebral oedema in the pathogenesis of cerebral malaria

Pages 137-142 | Published online: 19 Jul 2013

  • Turner G. Cerebral malaria. Brain Pathol 1997; 7: 569–582.
  • Kampfl AW, Birbamer GO, Pfausler BE, Haring HP, Schmutzhard E. Isolated pontine lesion in algid cerebral malaria: clinical features, management, and magnetic resonance imaging findings. Am J Trop Med Hyg 1993; 48: 818–822.
  • Marsh K, Forster D, Waruiru C et al. Indicators of life-threatening malaria in African children. N Engl J Med 1995; 332: 1399–1404.
  • van Hensbroek MB, Onyiorah E, Jaffar S et al. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 1996; 335: 69–75.
  • Cattani J, Davidson D, Engers H. Malaria. In: WHO. Tropical Disease Research: Progress 1991-92. Eleventh programme report UNDPIWorld Bank/WHO special programme for Research and Training in Tropical Diseases. Geneva: WHO, 1991-92; 15-27.
  • Rigdon RH. Pathological lesions in the brain in malaria. South Med J 1944; 37: 687–694.
  • Pongponratn E, Riganti M, Punpoowong B, Aikawa M. Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am J Trop Med Hyg 1991;44: 168–175.
  • Maegraith B, Fletcher A. The pathogenesis of mammalian malaria. Adv Parasitol 1972; 10: 49–75.
  • Clark IA, Rockett KA. The cytokine theory of human cerebral malaria. Parasitol Today 1994; 10: 410–412.
  • Grau GE. Essential role of tumor necrosis factor and other cytokines in the pathogenesis of cerebral malaria: experimental and clinical studies. Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie 1992; 54: 155–175.
  • Roman GC. Cerebral malaria: the unsolved riddle. J Neurol Sci 1991; 101: 1–6.
  • Riganti M, Pongponratn E, Tegoshi T, Looareesuwan S, Punpoowong B, Aikawa M. Human cerebral malaria in Thailand: a clinico-pathological correlation. Immunol Lett 1990; 25: 199–205.
  • White NJ, Warrell DA, Looareesuwan S, Chanthavanich P, Phillips RE, Pongpaew P. Pathophysiological and prognostic significance of cerebrospinal-fluid lactate in cerebral malaria. Lancet 1985; i: 776–778.
  • Warrell DA, White NJ, Veall Net al. Cerebral anaerobic glycolysis and reduced cerebral oxygen transport in human cerebral malaria. Lancet 1988; 534–538.
  • Grau GE, Tacchini CF, Vesin C et al. TNF-induced microvascular pathology: active role for platelets and importance of the LFA-1/ICAM-1 interaction. Eur Cytokine Netw 1993; 4: 415–419.
  • Thumwood CM, Hunt NH, Clark IA, Cowden WB. Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology 1988; 96: 579–589.
  • SenGupta SK, Naraqi S. The brain in cerebral malaria: a pathological study of 24 fatal cases in Papua New Guinea. Papua New Guinea Med J 1992; 35: 270–274.
  • Walker 0, Salako LA, Sowunmi A, Thomas JO, Sodeine 0, Bondi FS. Prognostic risk factors and post mortem findings in cerebral malaria in children. Trans R Soc Trop Med Hyg 1992; 86: 491–493.
  • Ma N, Madigan MC, Chan-Ling T, Hunt NH. Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria. Glia 1997; 19: 135–151.
  • Chan-Ling T, Neill AL, Hunt NH. Early microvascular changes in murine cerebral malaria detected in retinal wholemounts. Am J Pathol 1992; 140: 1121–1130.
  • Neill AL, Hunt NH. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology 1992; 105: 165–175.
  • Ma N, Hunt NH, Madigan MC, Chan-Ling T. Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria. Am J Pathol 1996; 149: 1745–1762.
  • Aikawa M, Pongponratn E, Tegoshi T et al. A study on the pathogenesis of human cerebral malaria and cerebral babesiosis. Memorias do Institut° Oswaldo Cruz 1992; 3: 297–301.
  • Jerusalem C, Polder T, Wijers-Rouw M et al. Comparative clinical and experimental study on the pathogenesis of cerebral malaria. Contrib Microbiol Immunol 1983; 7: 130-138.
  • Patnaik JK, Das BS, Mishra SK, Mohanty S, Satpathy SK, Mohanty D. Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria. Am J Trop Med Hyg 1994; 51: 642–647.
  • Miller JD, Ironside JW. Raised intracranial pressure, oedema and hydrocephalus. In: Graham DI, Lantos PL. (eds) Greenfield's Neuropathology, 6th edn. London: Oxford University Press; 1997; 157-195.
  • Staub F, Mackert B, Kempski O, Peters J, Baethmann A. Swelling and death of neuronal cells by lactic acid. J Neurol Sci 1993; 119: 79–84.
  • Heroux M, Butterworth RF. Animal models of the Wernicke-Korsakoff syndrome. Neuromethods 1992; 22: 95–131.
  • Harata N, Iwasaki Y. Evidence for early blood-brain barrier breakdown in experimental thiamine deficiency in the mouse. Metab Brain Dis 1995; 10: 159–174.
  • White NJ, Ho M. The pathophysiology of malaria. Adv Parasitol 1992; 31: 83–173.
  • Waller D, Crawley J, Nosten F et al. Intracranial pressure in childhood cerebral malaria. Trans R Soc Trop Med Hyg 1991; 85: 362–364.
  • Newton CR, Kirkham FJ, Winstanley PA et al. Intracranial pressure in African children with cerebral malaria. Lancet 1991; 337: 573–576.
  • Newton CR, Crawley J, Sowunmi A et al. Intracranial hypertension in Africans with cerebral malaria. Arch Dis Child 1997; 76: 219–226.
  • Newton CR, Peshu N, Kendall B et al. Brain swelling and ischaemia in Kenyans with cerebral malaria. Arch Dis Child 1994; 70: 281–287.
  • Looareesuwan S, Warrell DA, White NJ et al. Do patients with cerebral malaria have cerebral oedema? A computed tomography study. Lancet 1983; i: 434–437.
  • World Health Organization. Severe and complicated malaria, 2nd edn. Trans R Soc Trop Med Hyg 1990; 84 Suppl. 2: 1-65.
  • Warren DA, Looareesuwan S, Phillips RE et al. Function of the blood-cerebrospinal fluid barrier in human cerebral malaria: rejection of the permeability hypothesis. Am J Trop Med Hyg 1986; 35: 882–889.
  • Looareesuwan S, Wilairatana P, Krishna S et al. Magnetic resonance imaging of the brain in patients with cerebral malaria. Clin Infect Dis 1995; 21: 300–309.
  • Thumwood CM, Hunt NH, Cowden WB, Clark IA. Antioxidants can prevent cerebral malaria in Plasmodium berghei-infected mice. Br J Exp Pathol 1989; 70: 293–303.
  • Clark IA, Cowden WB. Why is the pathology of falciparum worse than that of vivax malaria. Parasitol Today 1999; 15: 458–461.
  • Clark IA, Rockett KA, Cowden WB. Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 1992; 340: 894–896.
  • Asensio VC, Oshima H, Falanga PB. Plasmodium berghei: is nitric oxide involved in the pathogenesis of mouse cerebral malaria? Exp Parasitol 1993; 77: 111-117.
  • Kremsner PG, Nussler A, Neifer S et al. Malaria antigen and cytokine-induced production of reactive nitrogen intermediates by murine macrophages: no relevance to the development of experimental cerebral malaria. Immunology 1993; 78: 286–290.
  • Al-Yaman FM, Mokela D, Genton B, Rockett KA, Alpers MP, Clark IA. Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea [see comments]. Trans R Soc Trop Med Hyg 1996; 90: 270–273.
  • Al-Yaman F, Awburn MM, Clark IA. Serum creatinine levels and reactive nitrogen intermediates in children with cerebral malaria in Papua New Guinea. Trans R Soc Trop Med Hyg 1997; 91: 303–305.
  • Rockett KA, Awburn MM, Aggarwal BB, Cowden WB, Clark IA. In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1: possible roles in malaria. Infect Immun 1992; 60: 3725–3730.
  • Sanni LA, Fu S, Dean RT et al. Are reactive oxygen species involved in the pathogenesis of murine cerebral malaria? J Infect Dis 1999; 179: 217–222.
  • Favre N, Ryffel B, Rudin W. The development of murine cerebral malaria does not require nitric oxide production. Parasitology 1999; 118: 135–138.
  • Saito K, Nowak TJ, Suyama K et al. Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation. J Neurochem 1993; 61: 2061–2070.
  • Alberati-Giani D, Ricciardi-Castagnoli P, Kohler C, Cesura AM. Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells. J Neurochem 1996; 66: 996–1004.
  • Kiskin NI, Krishtal OA, Tsyndrenko A. Cross-desensitization reveals pharmacological specificity of excitatory amino acid receptors in isolated hippocampal neurons. Eur J Pharmacol 1990; 2: 461–470.
  • Foster AC, Collins JF, Schwarcz R. On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds. Neuropharmacology 1983; 22: 1331–1342.
  • Sanni LA, Thomas SR, Tattam BN et al. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and non-cerebral malaria. Am J Pathol 1998; 152: 611–619.
  • Dobbie M, Crawley J, Waruiru C, Marsh K, Surtees R. Cerebrospinal fluid studies in children with cerebral malaria: an excitotoxic mechanism? Am J Trop Med Hyg 2000; 62: 284–290.
  • Thomas SR, Mohr D, Stocker R. Nitric oxide inhibits indole-amine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes. J Biol Chem 1994; 269: 14457–14464.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.